Background: The natural compounds caracasine acid (1) and its methyl ester, caracasine (2), isolated from the flowers of Croton micans, are effective against several tumor cell lines. Five semi-synthetic derivatives (3-7) were synthesized based on these structures. The study aimed to evaluate the cytotoxic activity of these compounds in 2D and spheroid cultures. Methods: The assays were performed in a panel of 12 human cell lines, 8 cancer and 4 normal cell lines. The compounds were evaluated on spheroids derived from the HCT116, HCT116 p53 knockout (p53KO), A549, and U2OS cell lines, as well as mixed spheroids comprising tumor cells and normal fibroblasts. Results: The parent compound (1), the natural ester (2), and two novel derivatives, the anhydride (7) and the cyclohexanol ester (3), demonstrated cytotoxicity against different leukemic cells and HCT116, HCT116 p53 knockout (p53KO), A549, and U2OS cell lines in conventional two-dimensional cultures. Peroxide formation, however, was significantly higher in leukemic cell lines (p < 0.01) in 2D culture as compared with the other tumor cell lines. The compounds did not induce cell death in spheroid cultures; caspases 8, 9, and 3 were not activated upon treatment. Conclusions: These findings indicate potential applications in leukemia treatment, albeit with limited efficacy against solid tumors.

Czech Advanced Technologies and Research Institute Institute of Molecular and Translational Medicine Palacky University 779 00 Olomouc Czech Republic

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University 779 00 Olomouc Czech Republic

Laboratory of Experimental Medicine University Hospital Olomouc 779 00 Olomouc Czech Republic

Unidad de Investigación en Productos Naturales Facultad de Farmacia Universidad Central de Venezuela Caracas 1040 Venezuela

Zobrazit více v PubMed

Coy-Barrera C.A., Galvis L., Rueda M.J., Torres-Cortés S.A. The Croton genus (Euphorbiaceae) and its richness in chemical constituents with a potential range of applications. Phytomed. Plus. 2025;5:100746. doi: 10.1016/j.phyplu.2025.100746. DOI

Guerrero-Solano J.A., Urrutia-Hernández T.A., Flores-Bazán T., Casco-Gallardo K.I., Coutiño-Laguna B.d.C., Vega-Cabrera N.V., Jaramillo-Morales O.A. Antinociceptive potential of Croton genus: A systematic review. Future Pharmacol. 2024;4:853–872. doi: 10.3390/futurepharmacol4040045. DOI

Obende S.O., Ochieng C.O., Shikanga E.A., Cruz J.N., Santos C.B.R., Kimani N.M. Croton’s therapeutic promise: A review of its phytochemistry and critical computacional ADME/Tox analysis. S. Afr. J. Bot. 2024;171:648–672. doi: 10.1016/j.sajb.2024.06.031. DOI

Espinoza-Hernández F.A., Moreno-Vargas A.D., Andrade-Cetto A. Diabetes-Related Mechanisms of Action Involved in the Therapeutic Effect of Croton Species: A Systematic Review. Plants. 2023;12:2014. doi: 10.3390/plants12102014. PubMed DOI PMC

Terefe E.M., Okalebo F.A., Derese S., Langat M.K., Mas-Claret E., Qureshi K.A., Jaremko M., Muriuki J. Anti-HIV Ermiasolides from Croton megalocarpus. Molecules. 2022;27:7040. doi: 10.3390/molecules27207040. PubMed DOI PMC

Terefe E.M., Okalebo F.A., Derese S., Muruki J., Batiha G.E.-S. In Vitro Cytotoxicity and Anti-HIV Activity of Crude Extracts of Croton macrostachyus, Croton megalocarpus and Croton dichogamus. J. Exp. Pharmacol. 2021;13:971–979. doi: 10.2147/JEP.S335104. PubMed DOI PMC

Nath R., Roy S., De B., Choudhury D. Anticancer and antioxidant activity of Croton: A review. Int. J. Pharm. Pharm. Sci. 2013;5:63–70.

Salatino A., Salatino M.L.F., Negri G. Traditional uses, chemistry and pharmacology of Croton species (Euphorbiaceae) J. Braz. Chem. Soc. 2007;18:11–33. doi: 10.1590/S0103-50532007000100002. DOI

Wu X.A., Zhao Y.M. Advance on chemical composition and pharmacological action of Croton L. Nat. Prod. Res. Dev. 2004;16:467–472.

Xu W.H., Liu W.Y., Liang Q. Chemical constituents from Croton species and their biological activities. Molecules. 2018;23:2333. doi: 10.3390/molecules23092333. PubMed DOI PMC

Fu Y., Li S., Zu Y., Yang G., Yang Z., Luo M., Jiang S., Wink M., Efferth T. Medicinal chemistry of paclitaxel and its analogues. Curr. Med. Chem. 2009;16:3966–3985. doi: 10.2174/092986709789352277. PubMed DOI

Qiu C.L., Ye Z.N., Yan B.C., Hu K., Yang J., Yang X.Z., Li H.M., Li X.N., Sun H.D., Puno P.T. Structurally diverse diterpenoids from Isodon oresbius and their bioactivity. Bioorg. Chem. 2022;124:105811. doi: 10.1016/j.bioorg.2022.105811. PubMed DOI

García P.B., de Oliveira A.B., Batista R. Occurrence, Biological Activities and Synthesis of Kaurane Diterpenes and their Glycosides. Molecules. 2007;12:455–483. doi: 10.3390/12030455. PubMed DOI PMC

Lee J.-E., Thuy N.T.T., Lee Y., Cho N., Yoo H.M. An Antiproliferative ent-Kaurane Diterpen Isolated from the Roots of Mallotus japonicus Induced Apoptosis in Leukemic Cells. Nat. Prod. Commun. 2020;15:897496. doi: 10.1177/1934578x19897496. DOI

Kibet S., Kimani N.M., Mwanza S.S., Mudalungu C.M., Santos C.B.R., Tanga C.M. Unveiling the Potential of Ent-Kaurane Diterpenoids: Multifaceted Natural Products for Drug Discovery. Pharmaceuticals. 2024;17:510. doi: 10.3390/ph17040510. PubMed DOI PMC

Trang N.T.K. The Review on Biological Activities of Ent-Kaurane Diterpenoids extracted from Croton tonkinensis. Thai Binh J. Med. Pharm. 2024;14:23–28. doi: 10.62685/tbjmp.2024.14.04. DOI

Hai Q.-X., Hu K., Chen S.-P., Fu Y.-Y., Li X.-N., Sun H.-D., He H.-P., Puno P.-T. Silvaticusins A–D: ent-kaurane diterpenoids and a cyclobutane-containing ent-kaurane dimer from Isodon silvaticus. Nat. Prod. Bioprospect. 2024;14:45. doi: 10.1007/s13659-024-00465-9. PubMed DOI PMC

Ibrahim T.S., Khongorzul P., Muyaba M., Alolga R.N. Ent-kaurane diterpenoids from the Annonaceae family: A review of research progress and call for further research. Front. Pharmacol. 2023;14:1227574. doi: 10.3389/fphar.2023.1227574. PubMed DOI PMC

Luo Y., Wang Z., Li Y., Zhang L. Longikaurin A, a natural ent-kaurane, suppresses proliferation, invasion and tumorigenicity in oral squamous cell carcinoma cell by via inhibiting PI3K/Akt pathway in vitro and in vivo. J. Cancer. 2025;16:708–719. doi: 10.7150/jca.102125. PubMed DOI PMC

Huang H.-T., Liaw C.-C., Lin Y.-C., Liao G.-Y., Chao C.-H., Chiou C.-T., Kuo Y.-H., Lee K.-T. New Diterpenoids from Mesona procumbens with Antiproliferative Activities Modulate Cell Cycle Arrest and Apoptosis in Human Leukemia Cancer Cells. Pharmaceuticals. 2021;14:1108. doi: 10.3390/ph14111108. PubMed DOI PMC

de Sousa I.P., Sousa Teixeira M.V., Jacometti Cardoso Furtado N.A. An Overview of Biotransformation and Toxicity of Diterpenes. Molecules. 2018;23:1387. doi: 10.3390/molecules23061387. PubMed DOI PMC

Tsichritzis F., Jakupovic J. Diterpenes and other Constituents from Relhania species. Phytochemistry. 1990;29:3173–3187. doi: 10.1016/0031-9422(90)80181-F. DOI

Li H., Jiao R., Mu M., Xu S., Li X., Wang X., Li Z., Xu J., Hua H., Li D. Bioactive Natural Spirolactone-Type 6,7-seco-ent-Kaurane Diterpenoids and Synthetic Derivatives. Molecules. 2018;23:2914. doi: 10.3390/molecules23112914. PubMed DOI PMC

Fan R.-Z., Chen L., Su T., Li W., Huang J.-L., Sang J., Tang G.-H., Yin S. Discovery of 8,9-seco-ent-Kaurane Diterpenoids as Potential Leads for the Treatment of Triple-Negative Breast Cancer. J. Med. Chem. 2021;64:9926–9942. doi: 10.1021/acs.jmedchem.1c00166. PubMed DOI

Sun H.-D., Huang S.-H., Han Q.-B. Diterpenoids from Isodon species and their biological activities. Nat. Prod. Rep. 2006;23:673–698. doi: 10.1039/b604174d. PubMed DOI

Ding G., Fei J., Wang J., Xie Y., Li R., Gong N., Lv Y., Yu C., Zou Z. Fimbriatols A–J, Highly Oxidized ent-Kaurane Diterpenoids from Traditional Chinese Plant Flickingeria fimbriata (B1.) Hawkes. Sci. Rep. 2016;6:30560. doi: 10.1038/srep30560. PubMed DOI PMC

Mora S., Castro V., Poveda L., Chavarr M., Murillo R. Two New 3,4-Seco-ent-kaurenes and Other Constituents from the Costa Rican Endemic Species Croton megistocarpus. Helv. Chim. Acta. 2011;94:1888–1892. doi: 10.1002/hlca.201100127. DOI

Suárez A.I., Chavez K., Delle Monache F., Vasquez L., Orsini G., Compagnone R.S. New 3,4-seco-entkaurenes from Croton caracasana Flowers. Nat. Prod. Comm. 2008;3:319–322. doi: 10.1177/1934578X0800300303. DOI

Fu Y.-Y., Hu K., Hou S.-Y., Yan B.-C., Li X.-N., Yang X.-Z., Sun H.-D., Puno P.-T. 8,14-seco-ent-Kaurane Diterpenoids from Isodon glutinosus: Enol-Enol Tautomerism and Antitumor Activity. Org. Chem. Front. 2025 doi: 10.1039/D5QO00356C. DOI

Mateu E., Chávez K., Riina R., Compagnone R.S., Delle Monache F., Suárez A.I. New 3,4-Seco-ent-kaurene Dimers from Croton micans. Nat. Prod. Comm. 2012;7:5–8. doi: 10.1177/1934578X1200700104. PubMed DOI

Suárez A.I., Chávez K., Mateu E., Compagnone R.S., Muñoz A., Sojo F., Arvelo F., Mijares M., De Sanctis J.B. Cytotoxic activity of seco-ent-kaurenes from Croton caracasana on human cancer cell lines. Nat. Prod. Comm. 2009;4:1547–1550. PubMed

Martínez G.P., Mijares M.R., Chávez K., Suárez A.I., Compagnone R.S., Chirinos P., De Sanctis J.B. Caracasine acid, an ent-3,4-seco-kaurene, promotes apoptosis and cell differentiation through NFkB signal pathway inhibition in leukemia cells. Eur. J. Pharmacol. 2019;862:172624. doi: 10.1016/j.ejphar.2019.172624. PubMed DOI

Martínez G.P., Mijares M.R., Chávez K., Chirinos P., Suárez A.I., De Sanctis J.B. Caracasine, an ent-kaurane diterpene with proapoptotic and pro-differentiator activity in human leukemia cell lines. Anticancer Agents Med. Chem. 2023;23:1145–1155. doi: 10.2174/1871520622666220415105615. PubMed DOI

Chávez K., Compagnone R.S., Alvarez A., Figarella K., Galindo-Castro I., Marsicobrete S., Trivino J., Arocha I., Taddei A., Orsini G., et al. Synthesis and biological evaluation of caracasine acid derivatives. Biorg. Med. Chem. 2015;23:3687–3695. doi: 10.1016/j.bmc.2015.04.015. PubMed DOI

Gutiérrez J.E., Fernandez-Moreira E., Rodríguez M.A., Mijares M.R., De Sanctis J.B., Gurská S., Džubák P., Hajdůch M., Bruno-Colmenarez J., Rojas L., et al. Novel 7-Chloro-(4-thioalkylquinoline) Derivatives: Synthesis and Antiproliferative Activity through Inducing Apoptosis and DNA/RNA Damage. Pharmaceuticals. 2022;15:1234. doi: 10.3390/ph15101234. PubMed DOI PMC

Jian Z.-P., Zou B.-H., Li X.-J., Liu J.-J., Shen L., Wu J. Ent-kauranes from the Chinese Excoecaria agallocha L. and NF-κB inhibitory activity. Fitoterapia. 2019;133:159–170. doi: 10.1016/j.fitote.2019.01.007. PubMed DOI

Htwe S.S., Harrington H., Knox A., Rose F., Aylott J., Haycock J.W., Ghaemmaghami A.M. Investigating NF-κB signaling in lung fibroblasts in 2D and 3D culture systems. Respir. Res. 2015;16:144. doi: 10.1186/s12931-015-0302-7. PubMed DOI PMC

Zhang L., Jin X. Nano and liposome cancer chemotherapy: A review of advances in drug delivery with applications. Int. J. Clin. Pharmacol. Ther. 2025;63:208–216. doi: 10.5414/CP204715. PubMed DOI

Figueroa D., Asaduzzaman M., Young F. Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2′,7′-dichlorofluorescin diacetate (DCFDA) assay. Pt 1J. Pharmacol. Toxicol. Method. 2018;94:26–33. doi: 10.1016/j.vascn.2018.03.007. PubMed DOI

Miyazato H., Taira J., Ueda K. Hydrogen peroxide derived from marine peroxy sesquiterpenoids induces apoptosis in HCT116 human colon cancer cells. Bioorg. Med. Chem. Lett. 2016;26:4641–4644. doi: 10.1016/j.bmcl.2016.08.057. PubMed DOI

Das V., Fürst T., Gurská S., Džubák P., Hajdúch M. Evaporation-reducing Culture Condition Increases the Reproducibility of Multicellular Spheroid Formation in Microtiter Plates. J. Vis. Exp. 2017;7:55403. doi: 10.3791/55403. PubMed DOI PMC

Muñoz-Garcia J., Jubelin C., Loussouarn A., Goumard M., Griscom L., Renodon-Cornière A., Heymann M.F., Heymann D. In vitro three-dimensional cell cultures for bone sarcomas. J. Bone Oncol. 2021;30:100379. doi: 10.1016/j.jbo.2021.100379. PubMed DOI PMC